General MedicationsINJECTIONGeneric

MUTAMYCIN

MITOMYCIN

Standard Dose

40MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview MUTAMYCIN is listed in Drugs@FDA under application 062336 (ANDA).

Marketing status: Discontinued Active ingredient MITOMYCIN Form and strength INJECTABLE;INJECTION - 40MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BRISTOL MYERS Submission history Latest submission status date: 2000-11-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview MUTAMYCIN is listed in Drugs@FDA under application 062336 (ANDA). Marketing status: Discontinued Active ingredient MITOMYCIN Form and strength INJECTABLE;INJECTION - 40MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BRISTOL MYERS Submission history Latest submission status date: 2000-11-02 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.